author-photo

Elena A. Filippova

14

Papers

38

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study.

2021 Translational Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma

2020 Journal of Modern Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Erlotinib in combined therapy of common lung adenocarcinoma in the presence of EGFR gene mutation

2019
Show All
- Source
- Cite
- Save
Citations (0)
1395PLung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical case of long-term pemetrexed-based chemotherapy treatment for pulmonary adenocarcinoma (ALA +)

2018
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim results of observational prospective study.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis

2018 Gene
Show All
- Source
- Cite
- Save
Citations (26)
Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants

2018 Biochimie
Show All
- Source
- Cite
- Save
Citations (10)
113PClinical outcomes and quality of life (QoL) in adults with advanced refractory non-small cell lung cancer (NSCLC) patients receiving nivolumab (Nivo) as 2+ line treatment: Interim analysis of expanded access program

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Observational study of the efficacy of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim analysis.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)